A luminescence-based assay for evaluating bactericidal antibody to Borrelia burgdorferi in vaccinated horses' serum

Equine Vet J. 2019 Sep;51(5):669-673. doi: 10.1111/evj.13074. Epub 2019 Feb 11.

Abstract

Background: Current serological tests cannot discriminate between bactericidal Borrelia burgdorferi antibodies from others that are merely a response to Borrelia antigenic stimulation.

Objective: To develop a sensitive and convenient luminescence-based serum bactericidal assay (L-SBA) to identify serum borreliacidal activity.

Study design: Prospective validation study and method comparison.

Methods: Serum samples were obtained either from archives of the Animal Health Diagnostic Center at Cornell University (N = 7) or from a vaccination trial (N = 238). Endogenous complement-inactivated serum sample was incubated with exogenic complement and B. burgdorferi ML23 pBBE22luc, which is able to process luciferin with luciferase and produce luminescence in viable Borrelia. After incubation, a light signal can be detected by using a luminometer to calculate the borreliacidal antibody titre.

Results: Components of the reaction mixture including spirochetes and complement from various sources and concentrations were tested to identify a reliable recipe for our complement-mediated L-SBA. We also applied this L-SBA on measuring bactericidal antibody activities and calculated the half inhibitory concentration (IC50 ) of serum samples from clinical collections. Furthermore, we analysed the L-SBA titres and anti-outer surface protein A (OspA) antibody levels from vaccinated horses using the multiplex assays and found that there is a relationship between results generated using these two different assays. The increases of L-SBA titres correlated with increases of anti-OspA antibody titre in sera (r = 0.423).

Main limitations: Immunoreactivity of commercial complement may differ from different batches. Clinical protection of borreliacidal antibody levels has not been determined.

Conclusions: The L-SBA provided a sensitive and easy-operating platform for the evaluation of bactericidal antibody to B. burgdorferi, and we anticipated L-SBA would function well as an evaluation tool of vaccine efficiency in the future.

Keywords: Borrelia burgdorferi; bactericidal; horse; luciferase; luminescence.

MeSH terms

  • Animals
  • Antibodies, Bacterial / blood*
  • Borrelia burgdorferi / immunology*
  • Horse Diseases / blood
  • Horse Diseases / prevention & control*
  • Horses
  • Luminescent Measurements / methods
  • Luminescent Measurements / veterinary*
  • Lyme Disease Vaccines / immunology*
  • Serum Bactericidal Antibody Assay / methods
  • Serum Bactericidal Antibody Assay / veterinary*

Substances

  • Antibodies, Bacterial
  • Lyme Disease Vaccines